New journals launched to address the diverse needs of the medical communities BMJ Group serves, supporting innovation in healthcare and fostering excellence in research
London, December 2024— BMJ Group, a global healthcare knowledge provider, announces the launch of five new journals dedicated to advancing medical research in critical areas. This expansion builds on the Group’s 65+ journal portfolio and underscores its commitment to open access (OA) publishing, ensuring that high quality research is globally accessible.
The first of the BMJ Connections journals, BMJ Connections Clinical Genetics and Genomics, provides an exclusive OA platform for groundbreaking genetic research.
BMJ Connections Oncology focuses on accelerating advancements in cancer research with a wide international scope, providing open access to studies in clinical, scientific, and translational oncology.
BMJ Digital Health & AI provides an essential space for the latest technology-integrated healthcare. It is launched alongside the BMJ Future Health community, an in-person conference and comprehensive programme of webinars and podcasts – designed for year-round learning and sharing of experiences on the transformative potential of MedTech and AI in healthcare.
Focusing on bioethics, JME Practical Bioethics addresses emerging ethical challenges of the twenty-first century, providing essential knowledge for decision making in clinical practice.
Launching in 2025, BMJ Immunology will have a hybrid publication model that meets the diverse needs of the immunology community, aligns with funder mandates, and supports inclusive research dissemination.
These launches come at a pivotal moment. As healthcare faces global challenges—from the rise of chronic disease to the incorporation of AI in clinical care—BMJ Group recognises the urgent need for specialised and reliable platforms to drive real-world impact. These journals will help to bridge gaps between research and practical application, empowering healthcare providers and policymakers across regions and resource levels.
“Amid growing demand for rapid, transparent access to transformative research, BMJ Group’s portfolio expansion reflects our dedication to driving medical advancement and supporting compliance with funder mandates. These new titles represent our unparalleled focus on fostering accessible, impactful research that improves patient care.”
Claire Rawlinson
Director of Growth Strategy, BMJ Group
With the flexibility of OA and hybrid models, BMJ Group supports global initiatives to make research more inclusive, especially in regions with limited access to subscription journals. As a leading provider of healthcare knowledge BMJ Group offers both gold and green OA publication options, enabling researchers worldwide to share their findings promptly, supporting equitable knowledge sharing and evidence-based healthcare improvements across borders.
[ENDS]
Notes for editors
About open access publishing routes at BMJ Group
BMJ Group is dedicated to making research openly available, thus providing multiple publishing routes. Offerings include the ‘gold’ route, where authors can pay an article processing charge (APC) to make their work immediately accessible, and the ‘green’ route, allowing authors to deposit draft manuscripts in repositories. The organisation also encourages sharing pre-review drafts on preprint servers, such as medRxiv, providing authors with flexible options regardless of their ability to pay an APC.
Contact us
For further information or to interview Claire Rawlinson, BMJ Group Publishing Director, please contact our media relations team: mediarelations@bmj.com / +44 (0)20 7383 6529 / +44 (0)20 7383 6920
Related posts
-
Driving global health research through BMJ collections -
Advancing global healthcare resilience -
Guiding global conversations in vaccine hesitancy -
BMJ Group unveils 2025 impact report, spotlighting global health influence and policy reach
